Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia

BACKGROUND: Myeloperoxidase (MPO) is a marker of plaque vulnerability and a mechanistic bridge between inflammation and cardiovascular disease, and thus is a suitable target for therapeutic strategy against cardiovascular disease. METHODS: Since hypercholesterolemia is associated with atherosclerosi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Puntoni, Mariarita, Sbrana, Francesco, Bigazzi, Federico, Minichilli, Fabrizio, Ferdeghini, Ezio, Sampietro, Tiziana
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2011
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3213072/
https://ncbi.nlm.nih.gov/pubmed/22014237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-10-185
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg